|
Volumn 533, Issue 1, 2001, Pages 83-89
|
Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRAIN DERIVED NEUROTROPHIC FACTOR;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
NERVE GROWTH FACTOR;
NEUROTROPHIC FACTOR;
NEUROTROPHIN 3;
NEUROTROPHIN 4;
ADENOVIRUS VECTOR;
CALCITONIN GENE RELATED PEPTIDE;
LEUKEMIA INHIBITORY FACTOR;
METHYLPREDNISOLONE;
RETROVIRUS VECTOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CELL LOSS;
CELL REGENERATION;
CELL TRANSPLANTATION;
CONTROLLED STUDY;
GENE THERAPY;
IMPLANTATION;
MAMMAL;
NERVE FIBER DEGENERATION;
NERVE FIBER GROWTH;
NERVE FIBER REGENERATION;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
REVIEW;
SCHWANN CELL;
SPINAL CORD FUNCTION;
SPINAL CORD INJURY;
SPINAL CORD NERVE CELL;
SYNAPSE;
ARTICLE;
CONTINUOUS INFUSION;
EX VIVO GENE TRANSFER;
FIBROBLAST;
NERVE SPROUTING;
SCHWANN CELL TRANSPLANTATION;
SPINAL CORD HEMISECTION;
SPINAL CORD TRANSSECTION;
THORACIC SPINAL CORD;
VIRAL GENE DELIVERY SYSTEM;
ANIMALS;
GENE THERAPY;
NERVE GROWTH FACTORS;
NERVE REGENERATION;
NEURONS;
SCHWANN CELLS;
SPINAL CORD INJURIES;
|
EID: 0035866993
PISSN: 00223751
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1469-7793.2001.0083b.x Document Type: Review |
Times cited : (235)
|
References (48)
|